Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC Patients
Clinical trial NCT03874000 · UNKNOWN
Trial details
- NCT number
- NCT03874000
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-08
- Primary completion
- 2022-02-28
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.